Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia · Delayed Price · Currency is MYR 0.2950
0.00 (0.00%)
At close: Feb 27, 2026
Pharmaniaga Berhad Revenue
In the year 2025, Pharmaniaga Berhad had annual revenue of 3.93B MYR with 4.48% growth. Pharmaniaga Berhad had revenue of 938.28M in the quarter ending December 31, 2025, with 1.28% growth.
Revenue
3.93B
Revenue Growth
+4.48%
P/S Ratio
0.49
Revenue / Employee
1.12M
Employees
3,502
Market Cap
1.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.93B | 168.27M | 4.48% |
| Dec 31, 2024 | 3.76B | 355.00M | 10.43% |
| Dec 31, 2023 | 3.40B | -76.45M | -2.20% |
| Dec 31, 2022 | 3.48B | -1.33B | -27.71% |
| Dec 31, 2021 | 4.82B | 2.09B | 76.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guan Chong Berhad | 15.30B |
| Aeon Co. (M) Bhd. | 4.31B |
| MBM Resources Berhad | 2.47B |
| Magnum Berhad | 2.30B |
| British American Tobacco (Malaysia) Berhad | 2.20B |
| Padini Holdings Berhad | 1.95B |
| Bumi Armada Berhad | 1.77B |
| Keck Seng (Malaysia) Berhad | 1.62B |